Article info

Download PDFPDF

Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

Authors

  1. Correspondence to Dr Eydie Miller Ellis, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Eydie.Miller{at}uphs.upenn.edu
View Full Text

Citation

Miller Ellis E, Berlin MS, Ward CL, et al
Ocular hypotensive effect of the novel EP3/FP agonist ONO-9054 versus Xalatan: results of a 28-day, double-masked, randomised study

Publication history

  • Received May 12, 2016
  • Revised August 4, 2016
  • Accepted August 10, 2016
  • First published September 20, 2016.
Online issue publication 
May 30, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.